home / stock / capr / capr quote
Last: | $4.82 |
---|---|
Change Percent: | 0.81% |
Open: | $4.9 |
Close: | $4.82 |
High: | $5.02 |
Low: | $4.7 |
Volume: | 478,366 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.82 | $4.9 | $4.82 | $5.02 | $4.7 | 478,366 | 04-23-2024 |
$4.94 | $4.99 | $4.94 | $5.11 | $4.92 | 357,005 | 04-22-2024 |
$5.01 | $5 | $5.01 | $5.28 | $4.87 | 354,057 | 04-19-2024 |
$5.05 | $5.6 | $5.05 | $5.65 | $4.685 | 935,721 | 04-18-2024 |
$5.55 | $5.98 | $5.55 | $6.05 | $5.44 | 484,149 | 04-17-2024 |
$5.93 | $5.77 | $5.93 | $6.03 | $5.69 | 276,550 | 04-16-2024 |
$5.86 | $6.27 | $5.86 | $6.33 | $5.65 | 344,673 | 04-15-2024 |
$6.25 | $6.11 | $6.25 | $6.29 | $6.03 | 166,012 | 04-12-2024 |
$6.23 | $6.28 | $6.23 | $6.47 | $6.01 | 372,874 | 04-11-2024 |
$6.3 | $6.57 | $6.3 | $6.71 | $6.06 | 311,458 | 04-10-2024 |
$6.6 | $6.55 | $6.6 | $6.76 | $6.45 | 225,835 | 04-09-2024 |
$6.58 | $6.72 | $6.58 | $6.8 | $6.54 | 121,798 | 04-08-2024 |
$6.72 | $6.7 | $6.72 | $6.82 | $6.51 | 269,173 | 04-05-2024 |
$6.7 | $6.79 | $6.7 | $7 | $6.69 | 238,304 | 04-04-2024 |
$6.8 | $6.94 | $6.8 | $7.07 | $6.64 | 165,895 | 04-03-2024 |
$6.89 | $6.97 | $6.89 | $7.065 | $6.85 | 189,417 | 04-02-2024 |
$7.095 | $6.79 | $7.095 | $7.28 | $6.73 | 413,949 | 04-01-2024 |
$6.79 | $6.74 | $6.79 | $6.935 | $6.6 | 185,085 | 03-29-2024 |
$6.79 | $6.74 | $6.79 | $6.935 | $6.6 | 185,085 | 03-28-2024 |
$6.77 | $6.29 | $6.77 | $7.04 | $6.19 | 382,715 | 03-27-2024 |
News, Short Squeeze, Breakout and More Instantly...
Capricor Therapeutics Inc. Company Name:
CAPR Stock Symbol:
NASDAQ Market:
Capricor Therapeutics Inc. Website:
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and ex...
2024-03-18 12:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases, announced today that the Company will present the positive 24-month ...